All stimulants, including all optical isomers, e.g
Its cytoprotective effects were first characterized in the GI tract, but subsequent research has extended these findings to tendons, ligaments, bone, muscle, and even neural tissue
The heart-rate cost is mostly the glucagon arm: GLP-1 on its own nudges heart rate up a little and then flattens, while glucagon carries the part that keeps climbing with the dose
The earlier phase 3 study tested two doses against placebo, and the results ran the opposite way to intuition: 0.05 mg/kg/day met the primary endpoint (16/35 responders, p=0.007) while the higher 0.10 mg/kg/day dose failed it (8/32, p=0.16) [3]
Investigators have studied BPC-157 in peripheral and central nervous system injury models, examining axonal regeneration rates, neuroprotective markers, and behavioral outcomes in animal subjects under research protocols
Pinero-Lambea C, Bodelon G, Fernandez-Perianez R, Cuesta AM, Alvarez-Vallina L, Fernandez LA